EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Behavioral Activation mHealth Application for Smoking Cessation: A Randomized Controlled Pilot Trial

Jaimee L Heffner iD, Edit Serfozo, Kelsey Baker, Melissa Gasser, Noreen Watson, Stacey B Daughters, Elisardo Becoňa, Jennifer B McClure iD

Nicotine and Tobacco Research · 2024

DOI: 10.1093/ntr/ntae137 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Nicotine and Tobacco Research, 2024. Verfasst von Jaimee L Heffner und 7 weiteren Autor:innen. Beteiligte Einrichtung: Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, WA, USA. Hauptthemen laut MEDLINE: Smoking Cessation, Telemedicine, Mobile Applications. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS, National Institutes of Health, National Institute on Drug Abuse.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Behavioral activation (BA) is an effective intervention for both depression and substance use disorders. Combining BA with a standard smoking cessation intervention may improve quit rates by addressing depressive symptoms, a key barrier to quitting. This study preliminarily evaluated the acceptability and efficacy of the BA-based Actify! mobile health application (mHealth app) for smoking cessation. Aims and Methods We conducted a pilot randomized controlled trial (n = 242) comparing Actify! with the National Cancer Institute’s (NCI) app for smoking cessation (QuitGuide) on acceptability (user satisfaction, app openings), smoking abstinence, and mechanisms of change (BA and depressive symptoms) at 8 weeks and 6 months postrandomization. Participants were US adults recruited online who smoked daily.

Results

Treatment satisfaction was uniformly higher in the Actify! arm. Number of app openings was similar across arms (M = 34.3 openings over 8 weeks in both arms). Self-reported 30-day point prevalence abstinence (PPA) at 8 weeks was 12.6% for Actify! versus 7.3% for QuitGuide. Differences in 30-day PPA continued through 6 months (18.5% for Actify! vs. 12.2% for QuitGuide). Changes between baseline and 8 weeks in depressive symptoms and BA favored Actify!. Planned subgroup analyses suggested greater benefit of Actify! among participants with pretreatment mild-to-moderate depression symptom severity compared to those with no depression symptoms.

Conclusions

Actify! showed considerable promise as a novel mHealth treatment, as evidenced by its high usage and higher user satisfaction and quit rates than QuitGuide at both short- and long-term follow-up. The next step is to evaluate Actify! in a fully powered efficacy trial.

Implications

Study findings demonstrate the promise of a BA-based mobile health app (Actify!) for smoking cessation as a population-level intervention that can effectively address depressive symptoms as a risk factor for worse smoking treatment outcomes. The Actify! app is the first standalone BA-based app to demonstrate potential for improved acceptability and efficacy relative to a standard care comparison app, with user satisfaction and smoking quit rates descriptively exceeding those of the NCI’s QuitGuide app.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Smoking CessationTelemedicineMobile ApplicationsHumansPilot ProjectsMaleFemaleAdultMiddle AgedDepressionBehavior TherapyPatient Satisfaction

Autor:innen und Institutionen

  • Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, WA, USA.
  • Department of Psychology, University of Washington, Seattle, WA, USA.
  • Department of Psychology and Neuroscience, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Department of Clinical Psychology and Psychobiology, University of Santiago de Compostela, Santiago de Compostela, Spain.
  • Kaiser Permanente Washington Health Research Institute, Seattle, WA, USA.

ORCID-Profile: Jaimee L Heffner, Jennifer B McClure

Förderung

  • NIDA NIH HHS
  • National Institutes of Health
  • National Institute on Drug Abuse

Zitieren

APA

Heffner, J. L., Serfozo, E., Baker, K., Gasser, M., Watson, N., Daughters, S. B., Becoňa, E., & McClure, J. B. (2024). Behavioral Activation mHealth Application for Smoking Cessation: A Randomized Controlled Pilot Trial. Nicotine and Tobacco Research. https://doi.org/10.1093/ntr/ntae137

Vancouver

Heffner JL, Serfozo E, Baker K, Gasser M, Watson N, Daughters SB, et al. Behavioral Activation mHealth Application for Smoking Cessation: A Randomized Controlled Pilot Trial. Nicotine and Tobacco Research. 2024. doi:10.1093/ntr/ntae137

BibTeX
@article{Heffner2024,
  author = {Heffner, Jaimee L and Serfozo, Edit and Baker, Kelsey and Gasser, Melissa and Watson, Noreen and Daughters, Stacey B and Becoňa, Elisardo and McClure, Jennifer B},
  title = {Behavioral Activation mHealth Application for Smoking Cessation: A Randomized Controlled Pilot Trial},
  journal = {Nicotine and Tobacco Research},
  year = {2024},
  doi = {10.1093/ntr/ntae137}
}
Kostenlos starten →